Home › Funds › PFIZER INC › BOLT

PFIZER INC position in BOLT

BOLT BIOTHERAPEUTICS INC · Health Care

PFIZER INC reported holding 31,305 shares of BOLT (BOLT BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$112K, representing 0.07% of its reported portfolio and ranking #15 among its reported holdings. PFIZER INC has disclosed BOLT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)31.30K sh
Reported value held$112.07K
Portfolio Weight0.07%
First reportedQ4 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How PFIZER INC's BOLT position evolved

PFIZER INC first disclosed a stake in BOLT in Q4 2024 at 626,109 shares (US$335K). Across 8 filings, PFIZER INC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 31,305 shares valued at US$112K. Notable position changes include a 95% trim in Q2 2025 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 626.11K $335.03K New
Q1 2025 626.11K $250.44K Hold
Q2 2025 31.30K $180.63K Reduce
Q3 2025 31.30K $166.54K Hold
Q4 2025 31.30K $171.18K Hold
Q1 2026 31.30K $137.12K Hold
Q2 2026 31.30K $133.83K Hold
Q3 2026 31.30K $112.07K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BOLT and 13F data

BOLT (BOLT BIOTHERAPEUTICS INC) is a Health Care company. 15 other funds we track also report a position in BOLT — the largest reported positions include Vivo Capital, LLC (US$279K), Board of Trustees of The Leland Stanford Junior University (US$139K), Lynx1 Capital Management LP (US$119K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BOLT

All BOLT fund holders →

FAQ

How long has PFIZER INC held BOLT?

PFIZER INC has disclosed BOLT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is PFIZER INC's current position in BOLT?

As of Q3 2026, PFIZER INC holds 31.30K shares of BOLT (BOLT BIOTHERAPEUTICS INC), valued at $112.07K, representing 0.07% of its reported portfolio and ranking #15.

Has PFIZER INC been buying or selling BOLT?

In the latest 13F filing (Q3 2026), PFIZER INC held unchanged its position in BOLT.

Which other funds hold BOLT?

Other major institutional holders of BOLT include Vivo Capital, LLC, Board of Trustees of The Leland Stanford Junior University, Lynx1 Capital Management LP, among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.